# Literature Analysis Template

## Purpose
Conduct comprehensive literature reviews, meta-analyses, and systematic reviews to synthesize medical evidence and inform clinical practice, research, and healthcare policy decisions.

## Template

```
You are a medical literature analysis specialist. Conduct [ANALYSIS_TYPE] on [RESEARCH_TOPIC] for [TARGET_AUDIENCE] using [METHODOLOGY_APPROACH] to address [RESEARCH_QUESTION] and provide [EVIDENCE_SYNTHESIS].

REVIEW OVERVIEW:

Review Identification:
- Review title: [REVIEW_TITLE]
- Review type: [REVIEW_TYPE] - Systematic review/Meta-analysis/Scoping review/Narrative review
- Registration number: [REGISTRATION_NUMBER] - PROSPERO/Other registry
- Version: [REVIEW_VERSION] - Date: [VERSION_DATE]
- Lead reviewer: [LEAD_REVIEWER]
- Institution: [LEAD_INSTITUTION]
- Funding source: [FUNDING_SOURCE]

Review Team:
Primary Reviewers:
- Reviewer 1: [REVIEWER_1] - Role: [REVIEWER_1_ROLE] - Expertise: [REVIEWER_1_EXPERTISE]
- Reviewer 2: [REVIEWER_2] - Role: [REVIEWER_2_ROLE] - Expertise: [REVIEWER_2_EXPERTISE]
- Reviewer 3: [REVIEWER_3] - Role: [REVIEWER_3_ROLE] - Expertise: [REVIEWER_3_EXPERTISE]

Additional Team Members:
- Statistician: [STATISTICIAN_NAME] - Institution: [STATISTICIAN_INSTITUTION]
- Librarian: [LIBRARIAN_NAME] - Role: [LIBRARIAN_ROLE]
- Content experts: [CONTENT_EXPERTS_LIST]
- Patient representative: [PATIENT_REPRESENTATIVE]

BACKGROUND AND RATIONALE:

Clinical Context:
Disease/Condition Overview:
[CLINICAL_CONDITION_OVERVIEW]
- Epidemiology: [CONDITION_EPIDEMIOLOGY]
- Burden of disease: [DISEASE_BURDEN]
- Natural history: [NATURAL_HISTORY]
- Current management: [CURRENT_MANAGEMENT]

Clinical Problem:
[CLINICAL_PROBLEM_STATEMENT]
- Knowledge gaps: [KNOWLEDGE_GAPS]
- Controversies: [CLINICAL_CONTROVERSIES]
- Practice variation: [PRACTICE_VARIATION]
- Unmet needs: [UNMET_CLINICAL_NEEDS]

Existing Evidence:
Previous Reviews:
- [PREVIOUS_REVIEW_1]: Date [PREVIOUS_DATE_1] - Limitations: [PREVIOUS_LIMITATIONS_1]
- [PREVIOUS_REVIEW_2]: Date [PREVIOUS_DATE_2] - Scope: [PREVIOUS_SCOPE_2]
- [PREVIOUS_REVIEW_3]: Date [PREVIOUS_DATE_3] - Findings: [PREVIOUS_FINDINGS_3]

Evidence Gaps:
- Methodological limitations: [METHODOLOGICAL_GAPS]
- Population gaps: [POPULATION_GAPS]
- Intervention gaps: [INTERVENTION_GAPS]
- Outcome measurement gaps: [OUTCOME_GAPS]

RESEARCH QUESTION:

PICO Framework:
Population:
- Target population: [TARGET_POPULATION]
- Demographics: [POPULATION_DEMOGRAPHICS]
- Setting: [POPULATION_SETTING]
- Disease characteristics: [DISEASE_CHARACTERISTICS]
- Severity/stage: [DISEASE_SEVERITY]

Intervention(s):
Primary Intervention:
- [PRIMARY_INTERVENTION] - Description: [INTERVENTION_DESCRIPTION]
- Dosing/delivery: [INTERVENTION_DOSING]
- Duration: [INTERVENTION_DURATION]
- Setting: [INTERVENTION_SETTING]

Comparator(s):
- [COMPARATOR_1] - Description: [COMPARATOR_DESCRIPTION_1]
- [COMPARATOR_2] - Placebo/standard care: [COMPARATOR_TYPE_2]
- [COMPARATOR_3] - Active control: [COMPARATOR_DESCRIPTION_3]

Outcomes:
Primary Outcomes:
1. [PRIMARY_OUTCOME_1] - Definition: [OUTCOME_DEFINITION_1] - Timeframe: [OUTCOME_TIMEFRAME_1]
2. [PRIMARY_OUTCOME_2] - Definition: [OUTCOME_DEFINITION_2] - Measurement: [OUTCOME_MEASUREMENT_2]

Secondary Outcomes:
1. [SECONDARY_OUTCOME_1] - Definition: [SECONDARY_DEFINITION_1]
2. [SECONDARY_OUTCOME_2] - Definition: [SECONDARY_DEFINITION_2]
3. [SECONDARY_OUTCOME_3] - Definition: [SECONDARY_DEFINITION_3]

Safety Outcomes:
- Adverse events: [AE_OUTCOMES] - Severity: [AE_SEVERITY_DEFINITIONS]
- Serious adverse events: [SAE_OUTCOMES]
- Discontinuation rates: [DISCONTINUATION_OUTCOMES]

Study Design:
Included Study Types:
- Randomized controlled trials: [RCT_INCLUSION]
- Observational studies: [OBSERVATIONAL_INCLUSION]
- Quasi-experimental: [QUASI_EXPERIMENTAL_INCLUSION]
- Case-control studies: [CASE_CONTROL_INCLUSION]
- Cohort studies: [COHORT_INCLUSION]

METHODOLOGY:

Protocol Development:
Protocol Registration:
- Registry: [PROTOCOL_REGISTRY]
- Registration date: [REGISTRATION_DATE]
- Protocol amendments: [PROTOCOL_AMENDMENTS]
- Deviations from protocol: [PROTOCOL_DEVIATIONS]

Guidelines Followed:
- PRISMA checklist: [PRISMA_COMPLIANCE]
- Cochrane methods: [COCHRANE_METHODS]
- GRADE approach: [GRADE_APPROACH]
- Other guidelines: [OTHER_GUIDELINES]

Search Strategy:

Database Selection:
Electronic Databases:
- MEDLINE/PubMed: [MEDLINE_SEARCH] - Date range: [MEDLINE_DATE_RANGE]
- Embase: [EMBASE_SEARCH] - Date range: [EMBASE_DATE_RANGE]
- Cochrane Library: [COCHRANE_SEARCH] - Components: [COCHRANE_COMPONENTS]
- Web of Science: [WOS_SEARCH] - Citation indices: [WOS_INDICES]
- CINAHL: [CINAHL_SEARCH] - For nursing literature: [CINAHL_FOCUS]
- PsycINFO: [PSYCINFO_SEARCH] - For psychological aspects: [PSYCINFO_FOCUS]

Specialized Databases:
- [SPECIALTY_DATABASE_1]: [SPECIALTY_PURPOSE_1]
- [SPECIALTY_DATABASE_2]: [SPECIALTY_PURPOSE_2]
- Clinical trial registries: [TRIAL_REGISTRIES]
- Conference proceedings: [CONFERENCE_SOURCES]

Search Terms:
Medical Subject Headings (MeSH):
- Primary MeSH terms: [PRIMARY_MESH_TERMS]
- Secondary MeSH terms: [SECONDARY_MESH_TERMS]
- Explosion and subheadings: [MESH_EXPLOSIONS]

Free Text Terms:
- Intervention terms: [INTERVENTION_SEARCH_TERMS]
- Population terms: [POPULATION_SEARCH_TERMS]
- Outcome terms: [OUTCOME_SEARCH_TERMS]
- Synonyms and variants: [SYNONYM_TERMS]

Search Strategy:
Boolean Operators:
[SEARCH_STRATEGY_DETAILS]
- AND combinations: [AND_COMBINATIONS]
- OR combinations: [OR_COMBINATIONS]
- NOT exclusions: [NOT_EXCLUSIONS]

Filters Applied:
- Date restrictions: [DATE_FILTERS]
- Language restrictions: [LANGUAGE_FILTERS]
- Publication type filters: [PUBLICATION_TYPE_FILTERS]
- Study design filters: [STUDY_DESIGN_FILTERS]

Additional Search Methods:
- Hand searching: [HAND_SEARCHING] - Journals: [HAND_SEARCHED_JOURNALS]
- Reference list screening: [REFERENCE_SCREENING]
- Citation searching: [CITATION_SEARCHING]
- Contact with experts: [EXPERT_CONTACT]
- Grey literature: [GREY_LITERATURE_SOURCES]

STUDY SELECTION:

Inclusion Criteria:
Study Characteristics:
1. [INCLUSION_CRITERION_1]
2. [INCLUSION_CRITERION_2]
3. [INCLUSION_CRITERION_3]
4. [INCLUSION_CRITERION_4]
5. [INCLUSION_CRITERION_5]

Population Criteria:
- Age range: [AGE_INCLUSION]
- Gender: [GENDER_INCLUSION]
- Disease characteristics: [DISEASE_INCLUSION]
- Setting: [SETTING_INCLUSION]

Intervention Criteria:
- Intervention type: [INTERVENTION_INCLUSION]
- Dose/intensity: [DOSE_INCLUSION]
- Duration: [DURATION_INCLUSION]
- Delivery method: [DELIVERY_INCLUSION]

Outcome Criteria:
- Required outcomes: [REQUIRED_OUTCOMES]
- Measurement tools: [MEASUREMENT_INCLUSION]
- Follow-up duration: [FOLLOWUP_INCLUSION]

Exclusion Criteria:
1. [EXCLUSION_CRITERION_1]
2. [EXCLUSION_CRITERION_2]
3. [EXCLUSION_CRITERION_3]
4. [EXCLUSION_CRITERION_4]
5. [EXCLUSION_CRITERION_5]

Selection Process:
Screening Stages:
Title/Abstract Screening:
- Number of reviewers: [TITLE_ABSTRACT_REVIEWERS]
- Disagreement resolution: [SCREENING_DISAGREEMENT_RESOLUTION]
- Pilot testing: [PILOT_SCREENING] - Articles: [PILOT_ARTICLES_NUMBER]
- Inter-rater agreement: [SCREENING_KAPPA]

Full-Text Review:
- Number of reviewers: [FULLTEXT_REVIEWERS]
- Exclusion documentation: [EXCLUSION_DOCUMENTATION]
- Final decision process: [FINAL_DECISION_PROCESS]

DATA EXTRACTION:

Data Extraction Form:
Study Characteristics:
- Study design: [EXTRACTED_STUDY_DESIGN]
- Setting: [EXTRACTED_SETTING]
- Country: [EXTRACTED_COUNTRY]
- Study period: [EXTRACTED_STUDY_PERIOD]
- Sample size: [EXTRACTED_SAMPLE_SIZE]
- Funding source: [EXTRACTED_FUNDING]

Population Data:
- Demographics: [EXTRACTED_DEMOGRAPHICS] - Age: [EXTRACTED_AGE] - Gender: [EXTRACTED_GENDER]
- Disease characteristics: [EXTRACTED_DISEASE_CHARACTERISTICS]
- Comorbidities: [EXTRACTED_COMORBIDITIES]
- Baseline severity: [EXTRACTED_BASELINE_SEVERITY]
- Previous treatments: [EXTRACTED_PREVIOUS_TREATMENTS]

Intervention Details:
- Intervention description: [EXTRACTED_INTERVENTION_DESCRIPTION]
- Dose/intensity: [EXTRACTED_DOSE]
- Frequency: [EXTRACTED_FREQUENCY]
- Duration: [EXTRACTED_DURATION]
- Co-interventions: [EXTRACTED_CO_INTERVENTIONS]
- Adherence: [EXTRACTED_ADHERENCE]

Outcome Data:
Primary Outcomes:
- [PRIMARY_OUTCOME_EXTRACTED_1]: Mean/proportion [OUTCOME_VALUE_1] - SD/CI [OUTCOME_VARIANCE_1]
- [PRIMARY_OUTCOME_EXTRACTED_2]: Effect size [EFFECT_SIZE_2] - Significance [SIGNIFICANCE_2]

Secondary Outcomes:
- [SECONDARY_OUTCOME_EXTRACTED_1]: [SECONDARY_VALUE_1]
- [SECONDARY_OUTCOME_EXTRACTED_2]: [SECONDARY_VALUE_2]
- [SECONDARY_OUTCOME_EXTRACTED_3]: [SECONDARY_VALUE_3]

Safety Data:
- Adverse events: [EXTRACTED_AE_DATA] - Number: [AE_COUNT] - Rate: [AE_RATE]
- Serious adverse events: [EXTRACTED_SAE_DATA]
- Withdrawals: [EXTRACTED_WITHDRAWAL_DATA] - Reasons: [WITHDRAWAL_REASONS]

Quality Assessment:
- Risk of bias tool: [BIAS_ASSESSMENT_TOOL]
- Overall quality rating: [OVERALL_QUALITY]
- Key limitations: [KEY_LIMITATIONS]

Data Extraction Process:
- Number of extractors: [DATA_EXTRACTORS_NUMBER]
- Independent extraction: [INDEPENDENT_EXTRACTION]
- Disagreement resolution: [EXTRACTION_DISAGREEMENT_RESOLUTION]
- Data verification: [DATA_VERIFICATION_PROCESS]

QUALITY ASSESSMENT:

Risk of Bias Assessment:
Assessment Tools:
For RCTs:
- Cochrane Risk of Bias 2.0: [ROB2_ASSESSMENT]
  - Randomization process: [ROB2_RANDOMIZATION]
  - Deviations from intervention: [ROB2_DEVIATIONS]
  - Missing outcome data: [ROB2_MISSING_DATA]
  - Measurement of outcome: [ROB2_OUTCOME_MEASUREMENT]
  - Selection of reported results: [ROB2_SELECTIVE_REPORTING]

For Observational Studies:
- Newcastle-Ottawa Scale: [NOS_ASSESSMENT]
  - Selection: [NOS_SELECTION]
  - Comparability: [NOS_COMPARABILITY]
  - Outcome: [NOS_OUTCOME]

GRADE Assessment:
Evidence Quality:
- Risk of bias: [GRADE_BIAS]
- Inconsistency: [GRADE_INCONSISTENCY]
- Indirectness: [GRADE_INDIRECTNESS]
- Imprecision: [GRADE_IMPRECISION]
- Publication bias: [GRADE_PUBLICATION_BIAS]
- Large effect: [GRADE_LARGE_EFFECT]
- Dose-response: [GRADE_DOSE_RESPONSE]

Overall Quality:
- High quality: [HIGH_QUALITY_EVIDENCE]
- Moderate quality: [MODERATE_QUALITY_EVIDENCE]
- Low quality: [LOW_QUALITY_EVIDENCE]
- Very low quality: [VERY_LOW_QUALITY_EVIDENCE]

STATISTICAL ANALYSIS:

Meta-Analysis Plan:
Statistical Software:
- Primary software: [META_ANALYSIS_SOFTWARE]
- Additional tools: [ADDITIONAL_STATISTICAL_TOOLS]
- Version: [SOFTWARE_VERSION]

Effect Measures:
- Continuous outcomes: [CONTINUOUS_EFFECT_MEASURE] - Mean difference/Standardized mean difference
- Binary outcomes: [BINARY_EFFECT_MEASURE] - Risk ratio/Odds ratio/Risk difference
- Time-to-event: [TIME_TO_EVENT_MEASURE] - Hazard ratio

Pooling Methods:
- Fixed effects model: [FIXED_EFFECTS_CONDITIONS]
- Random effects model: [RANDOM_EFFECTS_CONDITIONS]
- Model selection criteria: [MODEL_SELECTION_CRITERIA]

Heterogeneity Assessment:
- I² statistic: [I_SQUARED_INTERPRETATION]
- Chi-square test: [CHI_SQUARE_SIGNIFICANCE]
- Tau-squared: [TAU_SQUARED_INTERPRETATION]
- Prediction intervals: [PREDICTION_INTERVALS]

Sensitivity Analyses:
- Risk of bias sensitivity: [BIAS_SENSITIVITY_ANALYSIS]
- Study design sensitivity: [DESIGN_SENSITIVITY_ANALYSIS]
- Outlier analysis: [OUTLIER_SENSITIVITY_ANALYSIS]
- Fixed vs random effects: [MODEL_SENSITIVITY_ANALYSIS]

Subgroup Analyses:
Pre-specified Subgroups:
- [SUBGROUP_1]: [SUBGROUP_RATIONALE_1]
- [SUBGROUP_2]: [SUBGROUP_RATIONALE_2]
- [SUBGROUP_3]: [SUBGROUP_RATIONALE_3]

Subgroup Analysis Methods:
- Test for subgroup differences: [SUBGROUP_TEST_METHOD]
- Interaction testing: [INTERACTION_TEST_APPROACH]
- Multiple comparisons: [MULTIPLE_COMPARISONS_ADJUSTMENT]

Publication Bias Assessment:
- Funnel plots: [FUNNEL_PLOT_ASSESSMENT]
- Egger's test: [EGGERS_TEST_RESULTS]
- Begg's test: [BEGGS_TEST_RESULTS]
- Trim-and-fill: [TRIM_AND_FILL_ANALYSIS]

RESULTS:

Study Selection Results:
Search Results:
- Total records identified: [TOTAL_RECORDS_IDENTIFIED]
- Records after duplicates removed: [RECORDS_AFTER_DEDUPLICATION]
- Records screened: [RECORDS_SCREENED]
- Full-text articles assessed: [FULLTEXT_ASSESSED]
- Studies included in qualitative synthesis: [QUALITATIVE_SYNTHESIS_STUDIES]
- Studies included in quantitative synthesis: [QUANTITATIVE_SYNTHESIS_STUDIES]

Exclusion Reasons:
- [EXCLUSION_REASON_1]: n = [EXCLUSION_COUNT_1]
- [EXCLUSION_REASON_2]: n = [EXCLUSION_COUNT_2]
- [EXCLUSION_REASON_3]: n = [EXCLUSION_COUNT_3]
- [EXCLUSION_REASON_4]: n = [EXCLUSION_COUNT_4]

Study Characteristics:
Included Studies Summary:
- Total participants: [TOTAL_PARTICIPANTS]
- Study design distribution: [STUDY_DESIGN_DISTRIBUTION]
- Geographic distribution: [GEOGRAPHIC_DISTRIBUTION]
- Publication years: [PUBLICATION_YEARS_RANGE]
- Study quality distribution: [STUDY_QUALITY_DISTRIBUTION]

Population Characteristics:
- Age range: [PARTICIPANT_AGE_RANGE] - Mean age: [MEAN_PARTICIPANT_AGE]
- Gender distribution: [GENDER_DISTRIBUTION]
- Disease severity: [DISEASE_SEVERITY_DISTRIBUTION]
- Comorbidities: [COMORBIDITY_PREVALENCE]

Intervention Characteristics:
- Intervention types: [INTERVENTION_TYPES_SUMMARY]
- Dose ranges: [DOSE_RANGES]
- Treatment durations: [TREATMENT_DURATIONS]
- Settings: [INTERVENTION_SETTINGS]

Quality Assessment Results:
Risk of Bias Summary:
- Low risk: [LOW_RISK_STUDIES]% of studies
- Some concerns: [SOME_CONCERNS_STUDIES]% of studies
- High risk: [HIGH_RISK_STUDIES]% of studies

Common Bias Sources:
- [BIAS_SOURCE_1]: Present in [BIAS_PREVALENCE_1]% of studies
- [BIAS_SOURCE_2]: Present in [BIAS_PREVALENCE_2]% of studies
- [BIAS_SOURCE_3]: Present in [BIAS_PREVALENCE_3]% of studies

Meta-Analysis Results:
Primary Outcomes:
Outcome 1: [PRIMARY_OUTCOME_RESULT_1]
- Number of studies: [PRIMARY_STUDIES_1]
- Number of participants: [PRIMARY_PARTICIPANTS_1]
- Effect estimate: [PRIMARY_EFFECT_1] (95% CI: [PRIMARY_CI_1])
- P-value: [PRIMARY_P_VALUE_1]
- I² = [PRIMARY_I_SQUARED_1]% - Heterogeneity: [PRIMARY_HETEROGENEITY_1]

Outcome 2: [PRIMARY_OUTCOME_RESULT_2]
- Number of studies: [PRIMARY_STUDIES_2]
- Effect estimate: [PRIMARY_EFFECT_2] (95% CI: [PRIMARY_CI_2])
- P-value: [PRIMARY_P_VALUE_2]
- I² = [PRIMARY_I_SQUARED_2]%

Secondary Outcomes:
- [SECONDARY_OUTCOME_RESULT_1]: Effect [SECONDARY_EFFECT_1] (95% CI: [SECONDARY_CI_1])
- [SECONDARY_OUTCOME_RESULT_2]: Effect [SECONDARY_EFFECT_2] (95% CI: [SECONDARY_CI_2])
- [SECONDARY_OUTCOME_RESULT_3]: Effect [SECONDARY_EFFECT_3] (95% CI: [SECONDARY_CI_3])

Safety Results:
- Adverse events: RR [AE_RR] (95% CI: [AE_CI]) - P = [AE_P_VALUE]
- Serious adverse events: RR [SAE_RR] (95% CI: [SAE_CI])
- Discontinuations: RR [DISCONTINUATION_RR] (95% CI: [DISCONTINUATION_CI])

Subgroup Analysis Results:
Subgroup 1: [SUBGROUP_1_RESULTS]
- Effect in subgroup A: [SUBGROUP_A_EFFECT] (95% CI: [SUBGROUP_A_CI])
- Effect in subgroup B: [SUBGROUP_B_EFFECT] (95% CI: [SUBGROUP_B_CI])
- Test for subgroup differences: P = [SUBGROUP_DIFFERENCE_P]

Publication Bias Assessment:
- Funnel plot: [FUNNEL_PLOT_INTERPRETATION]
- Egger's test: P = [EGGERS_P_VALUE]
- Evidence of publication bias: [PUBLICATION_BIAS_CONCLUSION]

DISCUSSION:

Summary of Evidence:
Key Findings:
1. [KEY_FINDING_1]
2. [KEY_FINDING_2]
3. [KEY_FINDING_3]
4. [KEY_FINDING_4]

Strength of Evidence:
- Quality of evidence: [EVIDENCE_QUALITY_SUMMARY]
- Consistency of results: [RESULTS_CONSISTENCY]
- Magnitude of effect: [EFFECT_MAGNITUDE_INTERPRETATION]
- Clinical significance: [CLINICAL_SIGNIFICANCE]

Comparison with Previous Reviews:
- Similarities: [SIMILARITIES_WITH_PREVIOUS]
- Differences: [DIFFERENCES_FROM_PREVIOUS]
- New evidence: [NEW_EVIDENCE_CONTRIBUTION]
- Updated conclusions: [UPDATED_CONCLUSIONS]

Clinical Implications:
Practice Recommendations:
- [PRACTICE_RECOMMENDATION_1]
- [PRACTICE_RECOMMENDATION_2]
- [PRACTICE_RECOMMENDATION_3]

Patient Counseling:
- Benefits: [PATIENT_BENEFITS]
- Risks: [PATIENT_RISKS]
- Shared decision-making: [SHARED_DECISION_MAKING_GUIDANCE]

Policy Implications:
- Guidelines: [GUIDELINE_IMPLICATIONS]
- Resource allocation: [RESOURCE_IMPLICATIONS]
- Health technology assessment: [HTA_IMPLICATIONS]

Research Implications:
Future Research Needs:
- Research gaps: [FUTURE_RESEARCH_GAPS]
- Study design recommendations: [DESIGN_RECOMMENDATIONS]
- Population priorities: [POPULATION_RESEARCH_PRIORITIES]
- Outcome measurement: [OUTCOME_MEASUREMENT_RECOMMENDATIONS]

Limitations:
Study Limitations:
- Search limitations: [SEARCH_LIMITATIONS]
- Selection bias: [SELECTION_BIAS_LIMITATIONS]
- Data limitations: [DATA_LIMITATIONS]
- Analysis limitations: [ANALYSIS_LIMITATIONS]

Evidence Limitations:
- Study quality: [STUDY_QUALITY_LIMITATIONS]
- Heterogeneity: [HETEROGENEITY_LIMITATIONS]
- Generalizability: [GENERALIZABILITY_LIMITATIONS]
- Publication bias: [PUBLICATION_BIAS_LIMITATIONS]

CONCLUSIONS:

Main Conclusions:
Primary Conclusion:
[PRIMARY_CONCLUSION_STATEMENT]

Secondary Conclusions:
1. [SECONDARY_CONCLUSION_1]
2. [SECONDARY_CONCLUSION_2]
3. [SECONDARY_CONCLUSION_3]

Clinical Bottom Line:
[CLINICAL_BOTTOM_LINE_STATEMENT]

Research Bottom Line:
[RESEARCH_BOTTOM_LINE_STATEMENT]

COMPLETE LITERATURE ANALYSIS:

Review Summary:
Title: [FINAL_REVIEW_TITLE]
Type: [FINAL_REVIEW_TYPE]
Studies included: [FINAL_STUDIES_INCLUDED]
Participants: [FINAL_PARTICIPANTS_TOTAL]
Primary finding: [FINAL_PRIMARY_FINDING]
Evidence quality: [FINAL_EVIDENCE_QUALITY]

Lead Reviewer: [FINAL_LEAD_REVIEWER]
Institution: [FINAL_INSTITUTION]
Date completed: [FINAL_COMPLETION_DATE]

---

Review Quality Checklist:
✓ Systematic search conducted: [SEARCH_QUALITY_STATUS]
✓ Study selection objective: [SELECTION_QUALITY_STATUS]
✓ Data extraction standardized: [EXTRACTION_QUALITY_STATUS]
✓ Quality assessment performed: [QUALITY_ASSESSMENT_STATUS]
✓ Statistical methods appropriate: [STATISTICAL_METHODS_STATUS]
✓ Results clearly presented: [RESULTS_PRESENTATION_STATUS]
✓ Limitations acknowledged: [LIMITATIONS_STATUS]
✓ Conclusions justified: [CONCLUSIONS_STATUS]

Review quality: [OVERALL_REVIEW_QUALITY]
```

## Variables
[500+ variables covering comprehensive literature analysis including review methodology, search strategies, study selection, data extraction, quality assessment, statistical analysis, and evidence synthesis]

## Usage Examples

### Example 1: Systematic Review of Drug Efficacy
```
ANALYSIS_TYPE: "Systematic review and meta-analysis"
RESEARCH_TOPIC: "Effectiveness of ACE inhibitors in heart failure"
TARGET_AUDIENCE: "Cardiologists and general practitioners"
METHODOLOGY_APPROACH: "Cochrane systematic review methodology"
RESEARCH_QUESTION: "Do ACE inhibitors improve survival in heart failure patients"
EVIDENCE_SYNTHESIS: "Quantitative meta-analysis with GRADE assessment"
```

### Example 2: Scoping Review
```
ANALYSIS_TYPE: "Scoping review"
RESEARCH_TOPIC: "Digital health interventions for diabetes management"
TARGET_AUDIENCE: "Healthcare policymakers and researchers"
METHODOLOGY_APPROACH: "Arksey and O'Malley framework"
RESEARCH_QUESTION: "What digital interventions exist for diabetes care"
EVIDENCE_SYNTHESIS: "Narrative synthesis mapping evidence landscape"
```

### Example 3: Network Meta-Analysis
```
ANALYSIS_TYPE: "Network meta-analysis"
RESEARCH_TOPIC: "Comparative effectiveness of antidepressants"
TARGET_AUDIENCE: "Psychiatrists and mental health professionals"
METHODOLOGY_APPROACH: "Bayesian network meta-analysis"
RESEARCH_QUESTION: "Which antidepressant is most effective for depression"
EVIDENCE_SYNTHESIS: "Indirect comparison network analysis"
```

## Customization Options

1. **Analysis Types**
   - Systematic reviews
   - Meta-analyses
   - Network meta-analyses
   - Scoping reviews
   - Rapid reviews
   - Umbrella reviews
   - Narrative reviews
   - Living systematic reviews

2. **Research Topics**
   - Treatment effectiveness
   - Diagnostic accuracy
   - Prognostic factors
   - Risk factors
   - Healthcare interventions
   - Prevention strategies
   - Health outcomes
   - Healthcare delivery

3. **Target Audiences**
   - Clinicians
   - Researchers
   - Policymakers
   - Patients and families
   - Healthcare administrators
   - Regulatory agencies
   - Professional societies
   - Academic institutions

4. **Methodological Approaches**
   - Cochrane methods
   - PRISMA guidelines
   - JBI methodology
   - Campbell Collaboration
   - GRADE approach
   - Narrative synthesis
   - Framework synthesis
   - Thematic analysis